Article

VIDEO: Robert Frantz, MD, Talks About Bloodstream Infection Rates

Conference|CHEST: American College of Chest Physicians Annual Meeting

Robert Frantz, MD, FACC, Director, Pulmonary Hypertension Clinic, Mayo Clinic, discusses the rate of bloodstream infections in patients with pulmonary arterial hypertension treated with Veletri. Dr Franz also talks about the PROSPECT registry analysis.

Robert Frantz,

MD, FACC, Director, Pulmonary Hypertension Clinic, Mayo Clinic,

discusses the rate of bloodstream infections in patients with pulmonary arterial hypertension treated with Veletri. Dr Franz also talks about the PROSPECT registry analysis.

This video was taken on Sunday, October 21 at the CHEST 2012 conference in Atlanta, GA.

Related Videos
Anant Madabhushi, PhD.
Toby Maher, MD, PhD, professor of clinical medicine, Keck Medicine of USC
Dr Peter Schmid
Dr Sheela Rao
Davey Daniel, MD.
Meredith McKean, MD, MPH, board-certified medical oncologist and director of Melanoma and Skin Cancer Research for Sarah Cannon Research Institute at Tennessee Oncology
ERS 2024 Recap
Matthew Zachary, founder of Stupid Cancer.
Related Content
WCLC 2024 | Image Credit: © Christina Mattina
September 18th 2024

WCLC Researchers Focus on Multifaceted Lung Cancer Treatment Toxicities

Christina Mattina
The toxicity of lung cancer treatment has traditionally been discussed in terms of physical symptoms, but there is a growing focus on financial toxicity, time toxicity, and other effects on well-being, as reflected in research presented at the 2024 World Conference on Lung Cancer.
Image of Managed Care Cast logo
August 29th 2023

The Importance of Examining and Preventing Atrial Fibrillation

Maggie L. Shaw
At this year’s American Society for Preventive Cardiology Congress on CVD Prevention, Emelia J. Benjamin, MD, ScM, delivered the Honorary Fellow Award Lecture, “The Imperative to Focus on the Prevention of Atrial Fibrillation,” as the recipient of this year’s Honorary Fellow of the American Society for Preventive Cardiology award.
AI robot thinking | Image credit: phonlamaiphoto – stock.adobe.com
September 17th 2024

Are AI-Powered Robots the Future of Respiratory Health Care?

Hayden E. Klein
Introducing artificial intelligence (AI)–powered robots like AMECA into health care comes with potential benefits like improved clinical decision-making and faster diagnoses, but also presents challenges such as misinformation risks and data privacy concerns.
Managed Care Cast.
June 28th 2022

Promoting Equity in Public Health: Policy, Investment, and Community Engagement Solutions

Matthew Gavidia
On this episode of Managed Care Cast, we speak with Georges C. Benjamin, MD, executive director of the American Public Health Association, on the core takeaways of his keynote session at AHIP 2022 on public health policy and other solutions to promote equitable health and well-being.
Rising Incidence of Young-Onset Cancer: Exploring the Causes and Generational Risk Factors
September 16th 2024

Rising Incidence of Young-Onset Cancer: Causes and Generational Risk Factors

Alana Hippensteele
At ESMO Congress 2024, Shuji Ogino, MD, PhD, MS, explained that the rising incidence of young-onset cancer may be due to generational risk factors such as lifestyle, diet, and environmental changes, emphasizing the need for long-term research and follow up to understand early-life influences on cancer development.
Money | Image credit: Stillfx - stock.adobe.com
September 15th 2024

Incremental Effectiveness, Costs May Improve Using Biomarker-Guided Selection

Julia Bonavitacola
Lowered costs and incremental effectiveness could improve when using biomarker-guided selection for treatment of patients with metastatic colorectal cancer using first-line nivolumab.

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2024 MJH Life Sciences® and AJMC®.
All rights reserved.

About
Contact
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo